These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14535594)

  • 1. Are 90K/MAC-2BP serum levels correlated with poor prognosis in HCC patients? Preliminary results.
    Iacovazzi PA; Guerra V; Elba S; Sportelli F; Manghisi OG; Correale M
    Int J Biol Markers; 2003; 18(3):222-6. PubMed ID: 14535594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
    Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
    Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 90K/MAC-2BP glycoprotein levels in hepatocellular carcinoma and cirrhosis.
    Correale M; Giannuzzi V; Iacovazzi PA; Valenza MA; Lanzillotta S; Abbate I; Quaranta M; Caruso ML; Elba S; Manghisi OG
    Anticancer Res; 1999; 19(4C):3469-72. PubMed ID: 10629637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive significance of serum 90K/Mac-2BP on chemotherapy response in non-Hodgkin's lymphoma].
    Zhang DS; Jiang WQ; Li S; Zhang XS; Mao H; Chen XQ; Li YH; Zhan J; Wang FH
    Ai Zheng; 2003 Aug; 22(8):870-3. PubMed ID: 12917038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum protein 90K/Mac-2BP is an independent predictor of disease severity during hepatitis C virus infection.
    Kittl EM; Hofmann J; Hartmann G; Sebesta C; Beer F; Bauer K; Huber KR
    Clin Chem Lab Med; 2000 Mar; 38(3):205-8. PubMed ID: 10905755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients.
    Artini M; Natoli C; Tinari N; Costanzo A; Marinelli R; Balsano C; Porcari P; Angelucci D; D'Egidio M; Levrero M; Iacobelli S
    J Hepatol; 1996 Aug; 25(2):212-7. PubMed ID: 8878784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma.
    Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI
    Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
    Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
    Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical and serological 90K/Mac-2BP detection in hepatocellular carcinoma patients: different behaviour of two monoclonal antibodies.
    Valentini AM; Iacovazzi PA; Correale M; Pirrelli M; Armentano R; Iacobelli S; Tinari N; Iurisci I; Caruso ML
    Med Chem; 2005 Mar; 1(2):185-9. PubMed ID: 16787313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.
    Hussein MM; Ibrahim AA; Abdella HM; Montasser IF; Hassan MI
    Indian J Cancer; 2008; 45(4):167-72. PubMed ID: 19112206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of Preoperative Serum Alpha- fetoprotein in Hepatocellular Carcinoma and Correlation with Clinicopathological Factors: a Single-center Experience from China.
    An SL; Xiao T; Wang LM; Rong WQ; Wu F; Feng L; Liu FQ; Tian F; Wu JX
    Asian Pac J Cancer Prev; 2015; 16(10):4421-7. PubMed ID: 26028108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative serum α-fetoprotein and prognosis after hepatectomy for hepatocellular carcinoma.
    Yang SL; Liu LP; Yang S; Liu L; Ren JW; Fang X; Chen GG; Lai PB
    Br J Surg; 2016 May; 103(6):716-724. PubMed ID: 26996727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma.
    Yamashita S; Kato A; Akatsuka T; Sawada T; Asai T; Koyama N; Okita K
    World J Gastroenterol; 2020 Apr; 26(13):1463-1473. PubMed ID: 32308347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
    Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
    PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.
    Zhang XF; Yin ZF; Wang K; Zhang ZQ; Qian HH; Shi LH
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):618-23. PubMed ID: 23232633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP.
    Choi JY; Jung SW; Kim HY; Kim M; Kim Y; Kim DG; Oh EJ
    World J Gastroenterol; 2013 Jan; 19(3):339-46. PubMed ID: 23372355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma.
    Sun J; Xu HM; Zhou HJ; Dong QZ; Zhao Y; Fu LY; Hei ZY; Ye QH; Ren N; Jia HL; Qin LX
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):1-7. PubMed ID: 19593583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum DLK1 is a potential prognostic biomarker in patients with hepatocellular carcinoma.
    Li H; Cui ML; Chen TY; Xie HY; Cui Y; Tu H; Chen FH; Ge C; Li JJ
    Tumour Biol; 2015 Nov; 36(11):8399-404. PubMed ID: 26018510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.